HTRF®: Pioneering technology for high-throughput screening

Expert Opinion on Drug Discovery

Volumn 1, Issue 7, 2006, Pages 753-764

  Degorce, François ^a  

^a CIS Bio International   (France)

Author keywords

assay; fluorescence; FRET; GPCR screening; HTS; kinase screening; TR FRET

Indexed keywords

EID: 58049211410     PISSN: 17460441     EISSN: 1746045X     Source Type: Journal    
DOI: 10.1517/17460441.1.7.753     Document Type: Article

References (51)

1. GABRIEL D, VERNIER M, PFEIFER MJ, DASEN B, TENAILLON L, BOUHELAL R: High throughput screening technologies for direct cyclic AMP measurement. Assay Drug Dev. Technol. (2003) 2:291-303.
2. ALPHA B, LEHN JM, MATHIS G: Energy transfer luminescence of europium (III) and terbium (III) cryptates of macrobicyclic polypyridine ligands. Chem Int Ed Engl. (1987) 26:266-713.
3. TRINQUET E, BAZIN H, BLERIOT A, PICCIO V, AUTIERO H, MATHIS G: New europium cryptates to probe molecular interactions using HTRF. 6th annual conference of the Society for Biomolecular Screening. Vancouver, Canada. (2000)
4. TRINQUET E, MATHIS G: Fluorescence technologies for the investigation of chemical libraries. Mol Biosyst. 2006 Aug; 2(8):380-387.
5. BAZIN H, PRÉAUDAT M, TRINQUET E, MATHIS G: Homogeneous time resolved fluorescence resonance energy transfer using rare earth cryptates as a tool for probing molecular interactions in biology. Spectrochim. Acta. A. Mol. Biomol. Spectrosc. (2001) 57:2197-2211.
6. BAZIN H, TRINQUET E, MATHIS G: Time-resolved amplification of cryptate emission: a versatile technology to trace biomolecular interactions. J. Biotechnol.(2002) 82:233-250.
7. KOLB A, BURKE J, MATHIS G: A homogeneous, time-resolved fluorescence method for drug discovery. in: high throughput screening, the discovery of bioactive substances. Devlin JP, (Ed.) Marcel Dekker, Inc., New York (1997) (345)360.
8. KOLB J, YAMANAKE G, MANLYS: Use of a novel homogenous fluorescent technology in high throughput screening. J. Biomol. Screening (1996) 1:203-210.
9. MATHIS G: Homogeneous time resolved fluorescence, point-counterpoint. J. Biomol Screening. (1999) 4:309-313.
10. SITTAMPALAM GS, KAHI SD, JANZEN WP: High-throughput screening: advances in assay technologies. Curr. Opin. Chem. Biol. (1997) 1:384-91.
11. AMORAVAIN M, LYOTARD S, JAGA D, et al. : Introduction of a new HTRF® acceptor, d2. Development of a complete GPCR platform for a Gs, Gi and Gq screening. SBS 11th Annual Conference. Geneva, CH. (2005).
12. BONNET F, MENSAT P, ACHARD S et al.: HTRF® cyclic AMP assay: new optimized cell-based solutions for GPCR screening. IBCs 7th Annual Conference on G-Protein-coupled receptors. San Diego, USA (2002).
13. DREXLER C: HTRF KinEASE: a new solution for screening serine-threonine kinases. Nat. Methods (2006) 3:i-ii.
14. TRINQUET E, FINK M, GRILLET F et al.: IP-One assay: a new HTRF® assay to monitor Gq couple GPCR response. 3rd Annual European Conference on GPCRs in Drug Discovery, Amsterdam, Netherlands. (2005).
15. ACHARD S, JEAN A, LORPHELIN D, AMORAVAIN M, CLARET E: Homogeneous assays allow direct In Wells cytokine level quantification. Assay Drug Dev. Technol. (2003) 1:181-185.
16. CLARET E, OULED-DIAF J, SEGUIN P: Homogeneous time resolved fluorescence assay to measure histamine release. Comb. Chem. High Throughput Screen. (2003) 6:789-794.
17. CLARKE EE, SHEARMAN S: Quantitation of amyloid-β peptides in biological milieu using a novel homogeneous time-resolved fluorescence (HTRF®) assay. J. Neurosci. Meth. (2000) 102:61-68.
18. ENOMOTO K, AONO Y, MITSUGI T, SUZUKI R, PRÉAUDAT M, MATHIS G: High throughput screening for human interferon-gamma production using Homogeneous Time-Resolved Fluorescence. J. Biomol. Screen. (2000) 5:263-268.
19. KENNEDY ME,WANG W: Measuring human β-secretase (BACE1) activity using homogeneous time-resolved fluorescence. Anal. Biochem. (2003) 319:49-55.
20. MATHIS G: Probing molecular interactions with homogeneous techniques based on rare earth cryptates and fluorescence energy transfer. Clin Chem. (1995) 41:1391-1397.
21. MATHIS G: Homogeneous immunoassay and other applications of a novel fluorescence energy transfer technology using rare earth cryptates. J. Clin. Ligand Assay. (1997) 20:141-147.
22. MATHIS G: Rare earth cryptates and homogeneous fluoroimmunoassays with human sera. Clin Chem. (1993) 39:1953-1959.
23. MATHIS G, SOCQUET F, VIGUIER M, DARBOURET B: Homogeneous immunoassays using rare earth cryptates and time resolved fluorescence. Principles and specific advantages for tumor markers. Anticancer Res. (1997) 17:3011-3014.
24. MELLOR GW, BURDEN MN: Development of a CD28/CD86 (B7-2) binding assay for high throughput screening by homogenous time-resolved fluorescence. J. Biomol. Screen. (1998) 3:91-99.
25. TRINQUET E, MAURIN F, PRÉAUDAT M, MATHIS G: Allophycocyanin 1 as a near-infrared fluorescent tracer: isolation, characterization, chemical modification, and use in homogeneous fluorescence resonance energy transfer. Anal. Biochem. (2001) 296:232-244.
26. GALAUP C, PICARD C, CATHALA B et al.: Mono(di)nuclear Europium(lll) complexes of macrobi(tri)cyclic cryptands derived from diazatetralactams as luminophores in aqueous solution. Helv. Chim. Acta. (1999) 82:543-560.
27. TOZAWA-TAKAHASHI F, TANAKA Y et al.: Evaluation of IP-One, a new HTRF assay to monitor Gq coupled GPCR response. Comparison in HTS conditions with FLIPR. 11th SBS Annual Conference. Geneva, CH. (2005).
28. LOPEZ-CRAPEZ E, BAZIN H, ANDRE E, NOLETTI J, GRENIER J, MATHIS G. A homogeneous europium cryptate-based assay for the diagnosis of mutations by time-resolved fluorescence resonance energy transfer. Nucleic Acids Res. (2001) 29:14e70.
29. KANE SA, FLEENER CA, ZHANG YS, DAVIS LJ, MUSSELMAN AL, HUANG PS: Development of a binding assay for p53/HDM2 by using homogeneous time-resolved fluorescence. Anal. Biochem. (2000) 278:29-38.
30. KOLB AJ, KAPLITA PV, HAYES DJ et al.: Tyrosine kinase assays adapted to homogenous time-resolved fluorescence. Discovery Drug Technol. (1998) 3:333-342.
31. LEBLANC V, DELAUNAY V, LELONG JC, GAS F, MATHIS G, GRASSI J, MAY E: Homogeneous time-resolved fluorescence assay for identifying p53 interactions with its protein partners, directly in a cellular extract. Anal. Biochem. (2002) 308:247-254.
32. PRÉAUDAT M, OULED-DIAF J, ALPHA-BAZIN B et al.: A homogeneous caspase 3 activity assay using HTRF® technology. J. Biomol. Screening. (2002) 7:267-274.
33. YABUKI N, WATANABE S, KUDOH T, NIHIRA S, MIYAMOTO C: Application of homogeneous time-resolved fluorescence (HTRF®) to monitor poly-ubiquitination of wild-type p53. Comb. Chem. High Throughput Screen. (1999) 2:27-87.
34. ZHOU G, CUMMINGS R, HERMES J, MOLLER DE: Use of homogeneous time-resolved fluorescence energy transfer in the measurement of nuclear receptor activation. Methods. (2001) 25:54-61.
35. CENNI B, DREXLER C, GAVERIAUX S, ACHARD S, MARTINEZ S, SULOCHA S et al.: HTRF® cyclic AMP assay: new optimized cell-based assay for better investigation of Gi coupled receptors. Smart assays for screening, IIR congress, Zurich, CH. (2003).
36. THOMSEN W, FRAZER J, UNETT D: Functional assays for screening GPCR targets. Curr. Opin. Biotechnol. (2005) 16:655-665.
37. BADER B, KLOTZ M, ZOPF D, GLIENKE J, MARTINEZ S: Receptor tyrosine kinase screening - closer to physiology. SBS 9th Annual Conference. Portland, USA (2003).
38. HAMON J, MARTIN B, MEUNIER E, CASAMITJANA O, OUAGUED M, ROMAN F: Validation of the HTRF® technology for high throughput quantification of cAMP production mediated by activation of GPCR - comparison with flashplate. SBS 7th Annual Conference. Baltimore, USA (2001).
39. TRINQUET E, FINK M, BAZIN H et al.: D-myo-Inositol 1-phosphate as a surrogate of D-myo-inositol 1,4,5-tris phosphate to monitor G protein-coupled receptor activation Anal. Biochem. (2006) 358:126-135.
40. CHAMBON M, OTTO-BRUC A, HAMON H V, PERNELLE C: Screening and profiling for kinases: development of a unique and versatile platform. Miptec. Basel, CH. May (2005).
41. PARK YW, CUMMINGS RT, WU L et al.: Homogeneous proximity tyrosine kinase assays: scintillation proximity assay versus homogeneous time-resolved fluorescence. Anal Biochem. (1999) 269:94-104.
42. JIA Y, QUINN C, BUMP I et al.: Purification and kinetic characterization of recombinant human mitogen-activated protein kinase kinase kinase COT and the complexes with its cellular partner NF-kB1 p105. Arch. Biochem. Biophys. (2005) 441:64-74.
43. JIA Y, QUINN C, CLABBERS A, TALANIAN R, XU Y, WISHART N et al.: Comparative analysis of various in vitro COT kinase assay formats and their applications in inhibitor identification and characterization. Anal. Biochem. (2006) 350:268-276.
44. MCRAE B, WALLACE C, FITZGERALD DIXON K et al.: Suppression of CD4+ T cell activation by a novel inhibitor of Src family kinases. Internat. Immunopharm. (2005) 5:667-677.
45. YONG JIA, QUINN CM, GAGNON AI, TALANIAN R: Homogeneous time-resolved fluorescence and its applications for kinase assays in drug discovery. Anal. Biochem. (2006) (In Press).
46. OULED-DIAF J, RUSSELLO SV, ROURKE K, DEGORCE F, BUNKER C, CLARET EJ: Use of Europium cryptate labeled phospho-specific antibodies for high throughput kinase assays. Miptec. Basel, CH. (2003).
47. MABEL M, MATHIS G: US5527684 (2006).
48. http://www.htrf.com. Cisbio (2006).
49. http://www.htrf.com/resources/details/?tid=7 &rid=21 Cisbio international. HTRF resource library (2006).
50. http:/www./cerep.fr/cerep/users/pages/productsservices/popupkinase.asp Cerep. Description of HTRF kinase assay format (2004).
51. http://www.htrf.com/products/gpcr/ipone Cisbio international. Ip-One product description 2006.